Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ryan Specialty Holdings (RYAN) Total Liabilities (2020 - 2025)

Ryan Specialty Holdings (RYAN) has disclosed Total Liabilities for 6 consecutive years, with $9.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 8.87% to $9.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $9.3 billion, a 8.87% increase, with the full-year FY2025 number at $9.3 billion, up 8.87% from a year prior.
  • Total Liabilities was $9.3 billion for Q4 2025 at Ryan Specialty Holdings, up from $8.6 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $9.3 billion in Q4 2025 to a low of -$1.2 billion in Q2 2025.
  • A 5-year average of $4.7 billion and a median of $5.3 billion in 2023 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: surged 860559.82% in 2022, then plummeted 120.08% in 2024.
  • Ryan Specialty Holdings' Total Liabilities stood at $4.9 billion in 2021, then increased by 14.43% to $5.6 billion in 2022, then grew by 12.61% to $6.3 billion in 2023, then skyrocketed by 36.44% to $8.6 billion in 2024, then grew by 8.87% to $9.3 billion in 2025.
  • Per Business Quant, the three most recent readings for RYAN's Total Liabilities are $9.3 billion (Q4 2025), $8.6 billion (Q3 2025), and -$1.2 billion (Q2 2025).